Technology Industry has been focused on minimizing the impact of COVID-19 and marching ahead with its innovations and breakthroughs, be it critical components for semiconductors, cutting-edge data analytics or medical devices. We take a look at some tech companies that are impervious to the scare and...
C3.ai, Inc. (NYSE: AI) is a leading provider of enterprise software that enables digital transformation and building of enterprise-scale AI applications. The Company offers prebuilt, configurable, high-value AI applications that can be utilized in varied industries and areas such as energy management, customer management, supply...
Sierra Oncology, Inc. (NASDAQ: SRRA) is focussed on creating novel targeted therapies that address large unmet needs in rare forms of cancer. The Company’s lead product candidate is momelotinib, a selective and orally bioavailable JAK1, JAK2 and ACVR1/ALK2 inhibitor being developed for the treatment of...
Melanoma, a form of skin cancer, accounts for about 1% of skin cancers but is responsible for over 7,650 deaths every year as per an estimate by the American Cancer Society, these numbers are steadily rising over the years with approximately 99,780 new melanomas diagnosis being made each year. The...
Adicet Bio, Inc. (NASDAQ: ACET) is a biotechnology Company working on bringing allogeneic gamma delta T cell therapies for cancer and other therapies. The Company had merged with resTORbio, Inc. to create a combined entity, in September 2020. We take a look at the Company’s...
Technology Industry has been focused on minimizing the impact of COVID-19 and marching ahead with its innovations and breakthroughs, be it critical components for semiconductors, cutting-edge data analytics or medical devices. We take a look at some tech companies that are impervious to the scare and...
fuboTV, Inc. (NYSE: FUBO) is a live streaming platform that offers sports, news and entertainment channels for over 945 thousand paid subscribers. The Company has announced better-than-expected preliminary Q4 results with the revenue nearly $10 million higher than the initial forecast, besides adding 40,000 more...
Immunome, Inc. (NASDAQ: IMNM), a biopharmaceutical company developing novel first-in-class antibody therapeutics targeting oncology and infectious diseases, announced the receipt of a clinical hold letter from the U.S. Food and Drug Administration (FDA) for its recently submitted Investigational New Drug (IND) for IMM-BCP-01, a three-antibody...
Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches, advanced scientific knowledge and a zeal for innovation to the table. The Companies we have shortlisted this week have entered into strategic collaborations with some...
Vinco Ventures, Inc. (NASDAQ: BBIG), a stock that was once a favorite with the reddit crowd, has been on a roller coaster ride with the stock almost reaching quadruple value in 2021, making it yet another entrant in the list of Meme Stocks. However, like...
